Skip to main content
OpenTrials
Completed

NCT Number: NCT01338714

The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function

The aim of the study is to examine whether the compound herbal formula (RHD-1) is effective on HBV Carrier With Abnormal Liver Function.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Dysfunction Digestive System Diseases Liver Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Taipei City Hospital

Taipei, Taiwan, 886

About this study

% change HBV DNA title and liver function.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 40 < GPT <200 HBV carrier Age: 18-65 yrs old

Exclusion:

Creatinine >2.0 mg/dL Total bilirubin > 2.0mg/dL Not suitable patients diagnosis by physician in charge.

Treatment and study plan

Compound Herbal Formula (RHD-1)

Other

100 ml/per day

Other names: Chinese herbal medicine

dilute RHD-1

Other

100 ml/per day

Other names: Chinese herbal medicine dilute

Primary outcomes

  1. the % change of HBV DNA title

    Time frame: 6 weeks

Secondary outcomes

  1. the % change of GPT

    Time frame: 6 weeks

Sponsors and collaborators

Lead sponsor

Taipei City Hospital

Other Gov

Collaborators

  • National Yang Ming Chiao Tung University

Registry information

Official study title

The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function: a Randomized Controlled Trial

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Apr 19, 2011
Registry last updated
May 7, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.